Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 4;7(3):e243190.
doi: 10.1001/jamanetworkopen.2024.3190.

Prevalence of Lung Cancer Screening in the US, 2022

Louise M Henderson  1   2 , I-Hsuan Su  3 , M Patricia Rivera  4 , Joyce Pak  3 , Xiaomeng Chen  3 , Daniel S Reuland  2   5 , Jennifer L Lund  2   3
Affiliations

Prevalence of Lung Cancer Screening in the US, 2022

Louise M Henderson et al. JAMA Netw Open. .
No abstract available

Plain language summary

This cross-sectional study compares lung cancer screening prevalence in 2022 among individuals eligible by 2021 vs 2013 criteria by sociodemographics and state.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr. Henderson reported receiving grants from the National Institutes of Health during the conduct of the study. Dr Su reported receiving the Bristol-Myers Squibb (BMS)-University of North Carolina (UNC) Worldwide Health Economics and Outcomes Research Predoctoral Fellowship, with funds distributed through UNC and not directly from BMS, outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Lung Cancer Screening Prevalence Estimates for 2022
The forest plot presents 2022 lung cancer screening prevalence estimates and 95% CIs for individuals meeting 2013 and 2021 US Preventive Services Task Force eligibility criteria. Vertical lines indicate national 2022 lung cancer screening prevalence estimates using 2013 and 2021 eligibility criteria.
See this image and copyright information in PMC

References

    1. Moyer VA; U.S. Preventive Services Task Force . Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330-338. doi:10.7326/M13-2771 - DOI - PubMed
    1. Krist AH, Davidson KW, Mangione CM, et al. ; US Preventive Services Task Force . Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117 - DOI - PubMed
    1. Maki KG, Tan NQP, Toumazis I, Volk RJ. Prevalence of lung cancer screening among eligible adults in 4 US states in 2021. JAMA Netw Open. 2023;6(6):e2319172. doi:10.1001/jamanetworkopen.2023.19172 - DOI - PMC - PubMed
    1. Center for Disease Control and Prevention . Behavioral risk factor surveillance system. Updated January 9, 2024. Accessed October 25, 2023. https://www.cdc.gov/brfss/index.html
    1. Henderson LM, Rivera MP, Basch E. Broadened eligibility for lung cancer screening: challenges and uncertainty for implementation and equity. JAMA. 2021;325(10):939-941. doi:10.1001/jama.2020.26422 - DOI - PubMed

Publication types